XWD-28430-08979
5 vaccinations
7 coded responses
41 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 209 / MD
- Registered
- 2021-03-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-05
Registered in v-safe
-
2021-03-05
Dose 1 — Moderna
- 2021-03-05
-
2021-03-06
Survey response — days 1–6 daily, dose 1MedDRA: Cough, Rhinorrhoea, Sneezing — Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tiredness · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-03-07
Survey response — days 1–6 daily, dose 1MedDRA: Rhinorrhoea, Seasonal allergy, Self-medication — Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tiredness · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-03-08
Survey response — days 1–6 daily, dose 1MedDRA: Pre-existing disease, Self-medication — Feeling: GoodMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-03-09
Survey response — days 1–6 daily, dose 1MedDRA: Hypersensitivity, Pre-existing disease, Rhinorrhoea — Feeling: GoodMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-03-10
Survey response — days 1–6 daily, dose 1MedDRA: Hypersensitivity — Feeling: GoodMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-03-11
- 2021-03-12
- 2021-03-19
- 2021-03-26
-
2021-04-02
Dose 2 — Moderna
- 2021-04-02
-
2021-04-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-07-04
- 2021-10-01
-
2021-11-01
Dose 3 — Moderna
- 2021-11-01
- 2021-11-02
-
2021-11-03
Survey response — days 1–6 daily, dose 3MedDRA: Injection site erythema, Injection site swelling — Feeling: Good · Site: Redness · Rash, not including the immediate area around the injection siteMedDRA releases: 2024-11 · check-in answers available
- 2021-11-04
- 2021-11-06
-
2021-11-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Itching · NoneAdult check-in
- 2021-11-08
- 2021-11-15
-
2021-11-22
Survey response — 21 day, dose 3MedDRA: Office visit, Rash — Feeling: Good · Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11 · check-in answers available
-
2021-11-22
Report sent to call center — 21 day, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2021-11-29
- 2021-11-29
- 2021-12-06
- 2021-12-13
- 2022-01-31
-
2022-04-29
Dose 4 — Moderna
- 2022-07-29
- 2022-11-03
-
2022-11-06
Dose 5 — Moderna
- 2023-04-29
- 2023-05-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-05 | Moderna | |
| 2 | 2021-04-02 | Moderna | |
| 3 | 2021-11-01 | Moderna | No |
| 4 | 2022-04-29 | Moderna | No |
| 5 | 2022-11-06 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-11-22 | Unsuccessful |
Free text
Release 5
Systemic reaction (other): presentation of past seasonal allergy symptoms (sneezing and runny nose, and mild cough)
Systemic reaction (other): Persistent seasonal allergy, especially runny nose. Relieved by Zyrtec.
Systemic reaction (other): Persistent seasonal allergy symptoms, which coincided with first day following vaccination. Took one Zyrtec tablet to alleviate symptoms.
Systemic reaction (other): Seasonal allergy symptoms, only (runny nose, especially).
Systemic reaction (other): Seasonal allergy symptoms, which presented one day after vaccination, have improved since yesterday's check-in.
Release 10
Systemic reaction (other): Redness and mild swelling is below injection site and dissipating.
Symptoms: Rash on left lower leg, which is resolving with prescribed cortisone cream. (Rash first appeared on 11/16/21.)
Healthcare visit (other): outpatient visit to internist
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Hypersensitivity | ✓ | ✓ | ✓ |
| SRO | Injection site erythema | · | · | ✓ |
| SRO | Injection site swelling | · | · | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Seasonal allergy | ✓ | ✓ | ✓ |
| SRO | Self-medication | ✓ | ✓ | ✓ |
| SRO | Sneezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release